Edgewise Therapeutics Ownership 2024 | Who Owns Edgewise Therapeutics Now?


OverviewForecastRevenueFinancialsChart

Institutional Ownership

143.80%

Insider Ownership

0.47%

Retail Ownership

-44.27%

Institutional Holders

128.00

Edgewise Therapeutics Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ORBIMED ADVISORS LLC23.57%5.05%15,021,721454,5453.12%273,996,191Mar 31, 2024
RA CAPITAL MANAGEMENT, L.P.13.98%0.23%8,909,0918,909,091100.00%162,501,820Mar 31, 2024
FMR LLC9.99%0.01%6,365,724-126,789-1.95%116,110,807Mar 31, 2024
BAKER BROS. ADVISORS LP9.16%1.34%5,840,0592,727,27387.62%106,522,676Mar 31, 2024
BLACKROCK INC.8.11%0.00%5,167,0061,859,89656.24%94,246,190Mar 31, 2024
VANGUARD GROUP INC6.30%0.00%4,017,4331,892,05389.02%73,277,978Mar 31, 2024
VIKING GLOBAL INVESTORS LP5.24%0.23%3,339,146-2,820,000-45.79%60,906,023Mar 31, 2024
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.5.18%2.54%3,303,567636,36423.86%60,257,062Mar 31, 2024
CORMORANT ASSET MANAGEMENT, LP4.72%2.41%3,006,534454,54517.81%54,839,180Mar 31, 2024
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)4.51%0.91%2,874,586-1,058,551-26.91%52,432,449Mar 31, 2024
CITADEL ADVISORS LLC4.27%0.01%2,719,291133,3615.16%49,599,868Mar 31, 2024
PARADIGM BIOCAPITAL ADVISORS LP3.84%1.57%2,446,3732,446,373100.00%44,621,844Mar 31, 2024
PERCEPTIVE ADVISORS LLC3.64%0.73%2,319,6461,764,091317.54%42,310,343Mar 31, 2024
TCG CROSSOVER MANAGEMENT, LLC3.57%3.28%2,272,7282,272,728100.00%41,454,559Mar 31, 2024
VR ADVISER, LLC2.85%1.58%1,818,1821,818,182100.00%33,163,640Mar 31, 2024
JANUS HENDERSON GROUP PLC2.83%0.02%1,805,312590,29948.58%32,897,580Mar 31, 2024
GOLDMAN SACHS GROUP INC2.74%0.01%1,747,844865,94898.19%31,880,674Mar 31, 2024
NEW LEAF VENTURE PARTNERS, L.L.C.2.44%24.80%1,553,661--28,338,777Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC2.15%0.00%1,369,897422,85144.65%24,991,047Mar 31, 2024
DRIEHAUS CAPITAL MANAGEMENT LLC1.99%0.23%1,267,819872,750220.91%23,125,019Mar 31, 2024

Edgewise Therapeutics's largest institutional shareholder is ORBIMED ADVISORS LLC, holding 23.57% of the company's total share outstanding, currently valued at $274.00M. The top 10 institutional shareholders own together 90.77% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
NEW LEAF VENTURE PARTNERS, L.L.C.2.44%24.80%1,553,661--28,338,777Mar 31, 2024
ORBIMED ADVISORS LLC23.57%5.05%15,021,721454,5453.12%273,996,191Mar 31, 2024
TCG CROSSOVER MANAGEMENT, LLC3.57%3.28%2,272,7282,272,728100.00%41,454,559Mar 31, 2024
OPALEYE MANAGEMENT INC.1.04%2.78%665,000-34,000-4.86%12,129,600Mar 31, 2024
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.5.18%2.54%3,303,567636,36423.86%60,257,062Mar 31, 2024
CORMORANT ASSET MANAGEMENT, LP4.72%2.41%3,006,534454,54517.81%54,839,180Mar 31, 2024
VR ADVISER, LLC2.85%1.58%1,818,1821,818,182100.00%33,163,640Mar 31, 2024
PARADIGM BIOCAPITAL ADVISORS LP3.84%1.57%2,446,3732,446,373100.00%44,621,844Mar 31, 2024
PARKMAN HEALTHCARE PARTNERS LLC1.03%1.46%653,6532,0280.31%11,922,631Mar 31, 2024
BAKER BROS. ADVISORS LP9.16%1.34%5,840,0592,727,27387.62%106,522,676Mar 31, 2024
BIOIMPACT CAPITAL LLC0.69%1.29%441,259441,259100.00%8,048,564Mar 31, 2024
DAFNA CAPITAL MANAGEMENT LLC0.48%1.27%306,197-143,187-31.86%5,585,033Mar 31, 2024
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)4.51%0.91%2,874,586-1,058,551-26.91%52,432,449Mar 31, 2024
ADAR1 CAPITAL MANAGEMENT, LLC0.28%0.75%180,911180,911100.00%3,299,817Mar 31, 2024
PERCEPTIVE ADVISORS LLC3.64%0.73%2,319,6461,764,091317.54%42,310,343Mar 31, 2024
ECOR1 CAPITAL, LLC1.96%0.58%1,250,385-2,242,809-64.21%22,807,022Mar 31, 2024
QUANTUM PRIVATE WEALTH, LLC0.10%0.45%66,6743,4555.47%1,216,139Mar 31, 2024
GRANAHAN INVESTMENT MANAGEMENT, LLC0.95%0.39%608,012-466,896-43.44%11,090,139Mar 31, 2024
ARTAL GROUP S.A.1.27%0.38%811,718811,718100.00%14,805,736Mar 31, 2024
OXFORD ASSET MANAGEMENT LLP0.02%0.30%13,61513,615100.00%248,338Mar 31, 2024

The largest Edgewise Therapeutics shareholder by % of total assets is NEW LEAF VENTURE PARTNERS, L.L.C.. The company owns 1.55M shares of Edgewise Therapeutics (EWTX), representing 24.80% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
RA CAPITAL MANAGEMENT, L.P.13.98%0.23%8,909,0918,909,091100.00%162,501,820Mar 31, 2024
BAKER BROS. ADVISORS LP9.16%1.34%5,840,0592,727,27387.62%106,522,676Mar 31, 2024
PARADIGM BIOCAPITAL ADVISORS LP3.84%1.57%2,446,3732,446,373100.00%44,621,844Mar 31, 2024
TCG CROSSOVER MANAGEMENT, LLC3.57%3.28%2,272,7282,272,728100.00%41,454,559Mar 31, 2024
VANGUARD GROUP INC6.30%0.00%4,017,4331,892,05389.02%73,277,978Mar 31, 2024
BLACKROCK INC.8.11%0.00%5,167,0061,859,89656.24%94,246,190Mar 31, 2024
VR ADVISER, LLC2.85%1.58%1,818,1821,818,182100.00%33,163,640Mar 31, 2024
PERCEPTIVE ADVISORS LLC3.64%0.73%2,319,6461,764,091317.54%42,310,343Mar 31, 2024
DRIEHAUS CAPITAL MANAGEMENT LLC1.99%0.23%1,267,819872,750220.91%23,125,019Mar 31, 2024
GOLDMAN SACHS GROUP INC2.74%0.01%1,747,844865,94898.19%31,880,674Mar 31, 2024
ARTAL GROUP S.A.1.27%0.38%811,718811,718100.00%14,805,736Mar 31, 2024
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.5.18%2.54%3,303,567636,36423.86%60,257,062Mar 31, 2024
JANUS HENDERSON GROUP PLC2.83%0.02%1,805,312590,29948.58%32,897,580Mar 31, 2024
CORMORANT ASSET MANAGEMENT, LP4.72%2.41%3,006,534454,54517.81%54,839,180Mar 31, 2024
ORBIMED ADVISORS LLC23.57%5.05%15,021,721454,5453.12%273,996,191Mar 31, 2024
D. E. SHAW & CO., INC.0.74%0.01%473,680441,7301382.57%8,639,923Mar 31, 2024
BIOIMPACT CAPITAL LLC0.69%1.29%441,259441,259100.00%8,048,564Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC2.15%0.00%1,369,897422,85144.65%24,991,047Mar 31, 2024
MILLENNIUM MANAGEMENT LLC0.84%0.00%532,255400,900305.20%9,708,331Mar 31, 2024
STATE STREET CORP1.90%0.00%1,211,476318,76735.71%22,097,322Mar 31, 2024

As of Mar 31 2024, Edgewise Therapeutics's largest institutional buyer is RA CAPITAL MANAGEMENT, L.P.. The company purchased 8.91M stocks of EWTX, valued at $162.50M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
NOVO HOLDINGS A/S----6,071,703-100.00%-Mar 31, 2024
VIKING GLOBAL INVESTORS LP5.24%0.23%3,339,146-2,820,000-45.79%60,906,023Mar 31, 2024
DEEP TRACK CAPITAL, LP----2,537,176-100.00%-Mar 31, 2024
ECOR1 CAPITAL, LLC1.96%0.58%1,250,385-2,242,809-64.21%22,807,022Mar 31, 2024
HUDSON BAY CAPITAL MANAGEMENT LP----1,187,880-100.00%-Mar 31, 2024
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)4.51%0.91%2,874,586-1,058,551-26.91%52,432,449Mar 31, 2024
LOGOS GLOBAL MANAGEMENT LP----950,000-100.00%-Mar 31, 2024
BARCLAYS PLC0.14%0.00%87,244-691,672-88.80%1,591,000Mar 31, 2024
POINT72 ASSET MANAGEMENT, L.P.----501,256-100.00%-Mar 31, 2024
GRANAHAN INVESTMENT MANAGEMENT, LLC0.95%0.39%608,012-466,896-43.44%11,090,139Mar 31, 2024
SECTORAL ASSET MANAGEMENT INC----327,801-100.00%-Mar 31, 2024
VONTOBEL HOLDING LTD.----327,801-100.00%-Mar 31, 2024
IKARIAN CAPITAL, LLC----270,000-100.00%-Mar 31, 2024
AMERICAN CENTURY COMPANIES INC0.88%0.01%559,334-211,118-27.40%10,202,252Mar 31, 2024
ABRDN PLC----150,418-100.00%-Mar 31, 2024
DAFNA CAPITAL MANAGEMENT LLC0.48%1.27%306,197-143,187-31.86%5,585,033Mar 31, 2024
FMR LLC9.99%0.01%6,365,724-126,789-1.95%116,110,807Mar 31, 2024
PRICE T ROWE ASSOCIATES INC /MD/0.03%-16,424-109,647-86.97%300,000Mar 31, 2024
PALE FIRE CAPITAL SE----98,449-100.00%-Mar 31, 2024
BOOTHBAY FUND MANAGEMENT, LLC----72,117-100.00%-Mar 31, 2024

As of Mar 31 2024, Edgewise Therapeutics's biggest institutional seller is NOVO HOLDINGS A/S. The company sold -6.07M shares of EWTX, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
RA CAPITAL MANAGEMENT, L.P.13.98%0.23%8,909,0918,909,091100.00%162,501,820Mar 31, 2024
PARADIGM BIOCAPITAL ADVISORS LP3.84%1.57%2,446,3732,446,373100.00%44,621,844Mar 31, 2024
TCG CROSSOVER MANAGEMENT, LLC3.57%3.28%2,272,7282,272,728100.00%41,454,559Mar 31, 2024
VR ADVISER, LLC2.85%1.58%1,818,1821,818,182100.00%33,163,640Mar 31, 2024
ARTAL GROUP S.A.1.27%0.38%811,718811,718100.00%14,805,736Mar 31, 2024
BIOIMPACT CAPITAL LLC0.69%1.29%441,259441,259100.00%8,048,564Mar 31, 2024
ADAR1 CAPITAL MANAGEMENT, LLC0.28%0.75%180,911180,911100.00%3,299,817Mar 31, 2024
VOLORIDGE INVESTMENT MANAGEMENT, LLC0.28%0.01%175,901175,901100.00%3,208,434Mar 31, 2024
UBS GROUP AG0.12%0.00%74,11874,118100.00%1,351,912Mar 31, 2024
LIGHTHOUSE INVESTMENT PARTNERS, LLC0.10%0.05%60,88160,881100.00%1,110,469Mar 31, 2024
MARSHALL WACE, LLP0.09%0.00%54,61754,617100.00%996,215Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.04%0.00%26,87026,870100.00%490,109Mar 31, 2024
GRAHAM CAPITAL MANAGEMENT, L.P.0.04%0.01%26,84226,842100.00%489,598Mar 31, 2024
FRANKLIN RESOURCES INC0.03%0.00%20,00520,005100.00%364,891Mar 31, 2024
STATE OF WISCONSIN INVESTMENT BOARD0.03%0.00%19,60119,601100.00%357,522Mar 31, 2024
DENALI ADVISORS LLC0.03%0.10%19,20019,200100.00%350,208Mar 31, 2024
CASTLEVIEW PARTNERS, LLC0.03%0.17%16,20416,204100.00%295,561,000Mar 31, 2024
Y-INTERCEPT (HONG KONG) LTD0.02%0.02%14,90314,903100.00%271,831Mar 31, 2024
OXFORD ASSET MANAGEMENT LLP0.02%0.30%13,61513,615100.00%248,338Mar 31, 2024
NANTAHALA CAPITAL MANAGEMENT, LLC0.02%0.01%13,37113,371100.00%243,887Mar 31, 2024
ENTROPY TECHNOLOGIES, LP0.02%0.02%12,66512,665100.00%231,010Mar 31, 2024
STRS OHIO0.02%0.00%12,60012,600100.00%229,000Mar 31, 2024
FOX RUN MANAGEMENT, L.L.C.0.02%0.04%10,81410,814100.00%197,247Mar 31, 2024
ZURCHER KANTONALBANK (ZURICH CANTONALBANK)0.01%0.00%8,2158,215100.00%149,842Mar 31, 2024
QUEST PARTNERS LLC0.00%0.00%678678100.00%12,367Mar 31, 2024
FINANCIAL SYNERGIES WEALTH ADVISORS, INC.0.00%0.00%111111100.00%2,025,000Mar 31, 2024
COMERICA BANK0.00%-5757100.00%1,040,000Mar 31, 2024
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC--88100.00%145Mar 31, 2024

Edgewise Therapeutics's largest new institutional shareholder by number of shares is RA CAPITAL MANAGEMENT, L.P., purchased 8.91M shares, valued at $162.50M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
NOVO HOLDINGS A/S----6,071,703-100.00%-Mar 31, 2024
DEEP TRACK CAPITAL, LP----2,537,176-100.00%-Mar 31, 2024
HUDSON BAY CAPITAL MANAGEMENT LP----1,187,880-100.00%-Mar 31, 2024
LOGOS GLOBAL MANAGEMENT LP----950,000-100.00%-Mar 31, 2024
POINT72 ASSET MANAGEMENT, L.P.----501,256-100.00%-Mar 31, 2024
SECTORAL ASSET MANAGEMENT INC----327,801-100.00%-Mar 31, 2024
VONTOBEL HOLDING LTD.----327,801-100.00%-Mar 31, 2024
IKARIAN CAPITAL, LLC----270,000-100.00%-Mar 31, 2024
ABRDN PLC----150,418-100.00%-Mar 31, 2024
PALE FIRE CAPITAL SE----98,449-100.00%-Mar 31, 2024
BOOTHBAY FUND MANAGEMENT, LLC----72,117-100.00%-Mar 31, 2024
MARTINGALE ASSET MANAGEMENT L P----61,384-100.00%-Mar 31, 2024
JUMP FINANCIAL, LLC----47,100-100.00%-Mar 31, 2024
HRT FINANCIAL LP----38,788-100.00%-Mar 31, 2024
CHECKPOINT CAPITAL L.P.----33,000-100.00%-Mar 31, 2024
AJOVISTA, LLC----7,700-100.00%-Mar 31, 2024
NATIXIS----7,500-100.00%-Mar 31, 2024
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO----100-100.00%-Mar 31, 2024

Edgewise Therapeutics's largest sold out institutional shareholder by shares sold is NOVO HOLDINGS A/S, sold -6.07M shares, valued at -, as of undefined.

Edgewise Therapeutics Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
TEKLA LIFE SCIENCES INVESTORS0.26%150,418--Dec 31, 2023
FIDELITY ADVISOR SERIES VII0.10%866,300376,60076.90%Jan 31, 2024
ALGER FUNDS0.08%72,572--Jan 31, 2024
AMERICAN CENTURY MUTUAL FUNDS, INC.0.07%675,135221,45548.81%Jan 31, 2024
FIDELITY CAPITAL TRUST0.06%686,34512,5001.86%Jan 31, 2024
VANGUARD VALLEY FORGE FUNDS0.06%30,691--Dec 31, 2023
FIDELITY SECURITIES FUND0.03%3,187,72298,5613.19%Jan 31, 2024
FIDELITY SELECT PORTFOLIOS0.02%1,381,885728,100111.37%Feb 29, 2024
FORUM FUNDS II0.02%19,078--Jan 31, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.02%6,631--Dec 31, 2023
Vericimetry Funds0.01%1,420--Dec 31, 2023
QUANTITATIVE MASTER SERIES LLC0.01%79,6545,8797.97%Dec 31, 2023
Destra Investment Trust0.01%12,2205,58484.15%Dec 31, 2023
ETFis Series Trust I0.01%10,384--Jan 31, 2024
VANGUARD INDEX FUNDS0.01%2,477,839676,05537.52%Dec 31, 2023
DRIEHAUS MUTUAL FUNDS0.00%31,58731,587-Dec 29, 2023
ALPS ETF Trust0.00%46,7081,8784.19%Feb 29, 2024
FIDELITY COVINGTON TRUST0.00%36,24012,28351.27%Feb 29, 2024
FIDELITY CONCORD STREET TRUST0.00%426,01436,8699.47%Feb 29, 2024
Fidelity Commonwealth Trust II0.00%12,950--Aug 31, 2023
Calvert Variable Products, Inc.0.00%4,190--Dec 31, 2023
FIDELITY ADVISOR SERIES I0.00%249,300-87,300-25.94%Feb 29, 2024
SCHWAB STRATEGIC TRUST0.00%220,5767,5683.55%Feb 29, 2024
TIAA SEPARATE ACCOUNT VA 10.00%262--Dec 31, 2023
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%32,287--Dec 31, 2023
Principal Exchange-Traded Funds0.00%10,183-838-7.60%Mar 31, 2024
Brinker Capital Destinations Trust0.00%45,97645,1995817.12%Feb 29, 2024
Voya VARIABLE PORTFOLIOS INC0.00%18,185--Dec 31, 2023
GOLDMAN SACHS VARIABLE INSURANCE TRUST0.00%2,171--Dec 31, 2023
AMERICAN CENTURY ETF TRUST0.00%63,26328,73683.23%Feb 29, 2024
RBB FUND, INC.0.00%49,55049,550-Feb 29, 2024
Dimensional ETF Trust0.00%198,039153,301342.66%Jan 31, 2024
AMERICAN CENTURY STRATEGIC ASSET ALLOCATIONS INC0.00%6,0721,00419.81%Jan 31, 2024
JANUS INVESTMENT FUND0.00%133,390--Dec 31, 2023
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%1,946914.91%Dec 31, 2023
Fidelity Rutland Square Trust II0.00%381,45064,40020.31%Feb 29, 2024
Trust for Advised Portfolios0.00%4,835--Dec 31, 2023
TIAA-CREF LIFE FUNDS0.00%648--Dec 31, 2023
VARIABLE INSURANCE PRODUCTS FUND II0.00%2,415-750-23.70%Dec 31, 2023
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%13,8411,70014.00%Dec 31, 2023
T. Rowe Price Index Trust, Inc.0.00%2,573--Feb 29, 2024
VANGUARD WORLD FUND0.00%31,885--Feb 29, 2024
EQ ADVISORS TRUST0.00%116,0123,0712.72%Dec 31, 2023
VANGUARD SCOTTSDALE FUNDS0.00%187,97520,31112.11%Feb 29, 2024
RYDEX SERIES FUNDS0.00%390--Dec 31, 2023
GOLDMAN SACHS TRUST0.00%13,677--Feb 29, 2024
SA FUNDS INVESTMENT TRUST0.00%1,162--Dec 31, 2023
ProFunds0.00%61025069.44%Jan 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC0.00%59,024-69,091-53.93%Jan 31, 2024
VALIC Co I0.00%16,420-66-0.40%Feb 29, 2024
PROSHARES TRUST0.00%13,2153,63837.99%Feb 29, 2024
Invesco Exchange-Traded Self-Indexed Fund Trust0.00%11,160--Feb 29, 2024
VANGUARD WELLINGTON FUND0.00%19,78212,501171.69%Feb 29, 2024
NATIONWIDE VARIABLE INSURANCE TRUST0.00%6,605-3,269-33.11%Dec 31, 2023
RYDEX DYNAMIC FUNDS0.00%194--Dec 31, 2023
PENN SERIES FUNDS INC0.00%1,300--Dec 29, 2023
Federated Hermes Global Allocation Fund0.00%362--Feb 29, 2024
Guggenheim Active Allocation Fund0.00%225--Feb 29, 2024
NATIONWIDE MUTUAL FUNDS0.00%4,54746311.34%Jan 31, 2024
WILSHIRE MUTUAL FUNDS INC0.00%8,023-6-0.07%Dec 31, 2023
RYDEX VARIABLE TRUST0.00%26--Dec 31, 2023
TRUST FOR PROFESSIONAL MANAGERS0.00%6,5036,503-Feb 29, 2024
NORTHERN FUNDS0.00%19,088--Dec 29, 2023
SEI INSTITUTIONAL MANAGED TRUST0.00%61,04551,489538.81%Dec 31, 2023
HC CAPITAL TRUST0.00%586--Dec 31, 2023
COLLEGE RETIREMENT EQUITIES FUND0.00%20,664--Dec 31, 2023
MORGAN STANLEY PATHWAY FUNDS0.00%1,704--Feb 29, 2024
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST0.00%35,400--Dec 31, 2023
SUNAMERICA SERIES TRUST0.00%4,847-20-0.41%Jan 31, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST0.00%17,192-662-3.71%Dec 31, 2023
Invesco Exchange-Traded Fund Trust II0.00%2,4821,377124.62%Feb 29, 2024
Brighthouse Funds Trust II0.00%15,027--Dec 31, 2023
PACIFIC SELECT FUND0.00%17,358-784-4.32%Dec 31, 2023
Advisors' Inner Circle Fund III0.00%63--Jan 31, 2024
MASSMUTUAL SELECT FUNDS0.00%3,147--Dec 31, 2023
Bridge Builder Trust0.00%17,984--Dec 31, 2023
BlackRock Variable Series Funds, Inc.0.00%5,638--Dec 31, 2023
Blackstone Alternative Investment Funds0.00%100100-Dec 31, 2023
SEI INSTITUTIONAL INVESTMENTS TRUST0.00%8,300-3,370-28.88%Feb 29, 2024
John Hancock Funds II0.00%2,45395663.86%Feb 29, 2024

Edgewise Therapeutics's largest mutual fund holder by % of total assets is "TEKLA LIFE SCIENCES INVESTORS", owning 150.42K shares, compromising 0.26% of its total assets.

Edgewise Therapeutics Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 241289.40%
31 Dec, 2311736.05%
30 Sep, 2386-8.51%
30 Jun, 23949.30%
31 Mar, 2386-7.53%
31 Dec, 2293-2.11%
30 Sep, 229523.38%
30 Jun, 22778.45%
31 Mar, 227124.56%
31 Dec, 215721.28%
30 Sep, 21472.17%
30 Jun, 214648.39%
31 Mar, 2131-

As of 31 Mar 24, 128 institutions are holding Edgewise Therapeutics's shares, representing an increase of 9.40% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 2491,633,55715.13%
31 Dec, 2379,594,06716.34%
30 Sep, 2368,414,835-1.51%
30 Jun, 2369,464,5734.55%
31 Mar, 2366,438,859-0.23%
31 Dec, 2266,590,2133.43%
30 Sep, 2264,384,37926.33%
30 Jun, 2250,965,887-5.56%
31 Mar, 2253,964,5367.22%
31 Dec, 2150,332,8004.78%
30 Sep, 2148,038,2080.34%
30 Jun, 2147,877,1954.81%
31 Mar, 2145,681,359-

Edgewise Therapeutics (EWTX) has 91.63M shares outstanding as of 31 Mar 24, up 15.13% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 24143.80%0.91%
31 Dec, 23125.42%1.08%
30 Sep, 23107.94%0.90%
30 Jun, 23109.80%1.00%
31 Mar, 23105.02%0.68%
31 Dec, 22124.25%0.81%
30 Sep, 22124.19%1.18%
30 Jun, 22102.71%0.87%
31 Mar, 22108.92%0.61%
31 Dec, 21134.13%1.41%
30 Sep, 2197.51%1.03%
30 Jun, 2197.20%1.13%
31 Mar, 2192.74%-

As of 31 Mar 24, Edgewise Therapeutics is held by 143.80% institutional shareholders, representing a 0.91% growth compared to 31 Dec 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 249012.50%
31 Dec, 238063.27%
30 Sep, 2349-3.92%
30 Jun, 235137.84%
31 Mar, 2337-33.93%
31 Dec, 2256-5.08%
30 Sep, 225973.53%
30 Jun, 2234-19.05%
31 Mar, 2242-
31 Dec, 214282.61%
30 Sep, 2123-28.13%
30 Jun, 21323.23%
31 Mar, 2131-

90 institutional shareholders have increased their position in EWTX stock as of 31 Mar 24 compared to 80 in the previous quarter (a 12.50% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 242735.00%
31 Dec, 232017.65%
30 Sep, 2317-22.73%
30 Jun, 2322-15.38%
31 Mar, 232662.50%
31 Dec, 2216-27.27%
30 Sep, 2222-21.43%
30 Jun, 222855.56%
31 Mar, 2218500.00%
31 Dec, 213-72.73%
30 Sep, 211183.33%
30 Jun, 216-
31 Mar, 21--

27 institutional shareholders have reduced their position in EWTX stock as of 31 Mar 24 compared to 20 in the previous quarter (a 35.00% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 241289.40%91,633,55715.13%143.80%0.91%9012.50%2735.00%
31 Dec, 2311736.05%79,594,06716.34%125.42%1.08%8063.27%2017.65%
30 Sep, 2386-8.51%68,414,835-1.51%107.94%0.90%49-3.92%17-22.73%
30 Jun, 23949.30%69,464,5734.55%109.80%1.00%5137.84%22-15.38%
31 Mar, 2386-7.53%66,438,859-0.23%105.02%0.68%37-33.93%2662.50%
31 Dec, 2293-2.11%66,590,2133.43%124.25%0.81%56-5.08%16-27.27%
30 Sep, 229523.38%64,384,37926.33%124.19%1.18%5973.53%22-21.43%
30 Jun, 22778.45%50,965,887-5.56%102.71%0.87%34-19.05%2855.56%
31 Mar, 227124.56%53,964,5367.22%108.92%0.61%42-18500.00%
31 Dec, 215721.28%50,332,8004.78%134.13%1.41%4282.61%3-72.73%
30 Sep, 21472.17%48,038,2080.34%97.51%1.03%23-28.13%1183.33%
30 Jun, 214648.39%47,877,1954.81%97.20%1.13%323.23%6-
31 Mar, 2131-45,681,359-92.74%-31---

Edgewise Therapeutics Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 03, 2024MOORE JOHN Rofficer General CounselS-SaleSell1,956$18.91$36.99K3,252
May 03, 2024Carruthers R Michaelofficer Chief Financial OfficerS-SaleSell2,157$18.91$40.79K35,230
May 03, 2024Derakhshan Behradofficer Chief Business OfficerS-SaleSell1,718$18.91$32.49K13,422
May 03, 2024Russell Alan Jdirector, officer Chief Scientific OfficerS-SaleSell1,576$18.91$29.80K7,238
May 03, 2024Donovan Joanne M.officer CMOS-SaleSell3,682$18.91$69.63K19,897
May 03, 2024KOCH KEVINdirector, officer President and CEOS-SaleSell3,152$18.91$59.60K14,478

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 03, 2024MOORE JOHN Rofficer General CounselM-ExemptSell5,208--5,209
May 03, 2024MOORE JOHN Rofficer General CounselS-SaleSell1,956$18.91$36.99K3,252
May 03, 2024Carruthers R Michaelofficer Chief Financial OfficerS-SaleSell2,157$18.91$40.79K35,230
May 03, 2024Carruthers R Michaelofficer Chief Financial OfficerM-ExemptSell5,208--5,209
May 03, 2024Derakhshan Behradofficer Chief Business OfficerS-SaleSell1,718$18.91$32.49K13,422
May 03, 2024Derakhshan Behradofficer Chief Business OfficerM-ExemptSell5,208--5,209
May 03, 2024Russell Alan Jdirector, officer Chief Scientific OfficerS-SaleSell1,576$18.91$29.80K7,238
May 03, 2024Russell Alan Jdirector, officer Chief Scientific OfficerM-ExemptSell5,208--5,209
May 03, 2024Donovan Joanne M.officer CMOS-SaleSell3,682$18.91$69.63K19,897
May 03, 2024Donovan Joanne M.officer CMOM-ExemptSell10,417--10,417
May 03, 2024KOCH KEVINdirector, officer President and CEOS-SaleSell3,152$18.91$59.60K14,478
May 03, 2024KOCH KEVINdirector, officer President and CEOM-ExemptSell10,417--10,417

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 07, 2024Morris Arlenedirector-A-AwardBuy34,311$20.34$697.89K34,311
May 07, 2024Morris Arlene-Buy----
May 03, 2024MOORE JOHN Rofficer General CounselM-ExemptSell5,208--5,209
May 03, 2024MOORE JOHN Rofficer General CounselM-ExemptBuy5,208--5,208
May 03, 2024MOORE JOHN Rofficer General CounselS-SaleSell1,956$18.91$36.99K3,252
May 03, 2024Carruthers R Michaelofficer Chief Financial OfficerM-ExemptBuy5,208--37,387
May 03, 2024Carruthers R Michaelofficer Chief Financial OfficerS-SaleSell2,157$18.91$40.79K35,230
May 03, 2024Carruthers R Michaelofficer Chief Financial OfficerM-ExemptSell5,208--5,209
May 03, 2024Derakhshan Behradofficer Chief Business OfficerM-ExemptBuy5,208--15,140
May 03, 2024Derakhshan Behradofficer Chief Business OfficerS-SaleSell1,718$18.91$32.49K13,422
May 03, 2024Derakhshan Behradofficer Chief Business OfficerM-ExemptSell5,208--5,209
May 03, 2024Russell Alan Jdirector, officer Chief Scientific OfficerM-ExemptBuy5,208--8,814
May 03, 2024Russell Alan Jdirector, officer Chief Scientific OfficerS-SaleSell1,576$18.91$29.80K7,238
May 03, 2024Russell Alan Jdirector, officer Chief Scientific OfficerM-ExemptSell5,208--5,209
May 03, 2024Donovan Joanne M.officer CMOM-ExemptBuy10,417--23,579
May 03, 2024Donovan Joanne M.officer CMOS-SaleSell3,682$18.91$69.63K19,897
May 03, 2024Donovan Joanne M.officer CMOM-ExemptSell10,417--10,417
May 03, 2024KOCH KEVINdirector, officer President and CEOM-ExemptBuy10,417--17,630
May 03, 2024KOCH KEVINdirector, officer President and CEOS-SaleSell3,152$18.91$59.60K14,478
May 03, 2024KOCH KEVINdirector, officer President and CEOM-ExemptSell10,417--10,417

The last insider sell of Edgewise Therapeutics's stock was made by MOORE JOHN R on May 03 2024, selling 5,208 shares at - per share (valued at -).

Edgewise Therapeutics Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 202471258.33%
Q1 202491464.29%
Q4 20231250.00%
Q3 20237--
Q2 2023121392.31%
Q1 20231--
Q4 202222100.00%
Q3 202296150.00%
Q2 2022189200.00%
Q1 20221250.00%
Q4 20213319.68%
Q3 20216875.00%
Q2 20211--
Q1 2021175034.00%

7 total buy trades, and 12 total sell trades (buy/sell ratio of 0.58%) were made by Edgewise Therapeutics's insiders, as of Q2 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024-6-
Q1 20242728.57%
Q4 20231250.00%
Q3 2023---
Q2 2023-6-
Q1 2023---
Q4 2022-1-
Q3 202233100.00%
Q2 20223560.00%
Q1 2022---
Q4 2021-28-
Q3 2021-8-
Q2 2021---
Q1 20217--

As of Q2 2024, Insider owners conducted 0 open market buy trades and 6 open market sell trades of Edgewise Therapeutics's stocks.

Edgewise Therapeutics Peer Ownership


TickerCompany
MLYSMineralys Therapeutics, Inc.
DSGNDesign Therapeutics, Inc.
CCCCC4 Therapeutics, Inc.
ELYMEliem Therapeutics, Inc.
PASGPassage Bio, Inc.
TALSTourmaline Bio, Inc.
DBTXDecibel Therapeutics, Inc.
IPSCCentury Therapeutics, Inc.
BDTXBlack Diamond Therapeutics, Inc.
VORVor Biopharma Inc.
HOWLWerewolf Therapeutics, Inc.
BCELAtreca, Inc.
RVMDRevolution Medicines, Inc. Warrant
CGEMCullinan Oncology, Inc.
IKNAIkena Oncology, Inc.
XLOXilio Therapeutics, Inc.
ACETAdicet Bio, Inc.
CELCCelcuity Inc.

EWTX Ownership FAQ


Edgewise Therapeutics is owned by institutional shareholders (143.80%), insiders (0.47%), and public (-44.27%). The largest institutional shareholder of Edgewise Therapeutics is ORBIMED ADVISORS LLC (23.57% of total shares) and the top mutual fund owner is TEKLA LIFE SCIENCES INVESTORS (0.26% of total shares).

Edgewise Therapeutics's major institutional shareholders are ORBIMED ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P., FMR LLC, BAKER BROS. ADVISORS LP, and BLACKROCK INC.. The top five shareholders own together 64.82% of the company's share outstanding.

As of Mar 2024, there are 128 institutional shareholders of Edgewise Therapeutics.

ORBIMED ADVISORS LLC owns 15.02M shares of Edgewise Therapeutics, representing 23.57% of the company's total shares outstanding, valued at $274M (as of Mar 2024).

As of Mar 2024, RA CAPITAL MANAGEMENT, L.P holds 8.91M shares of Edgewise Therapeutics (EWTX), compromising 13.98% of the company, valued at $162.5M.

FMR LLC is the third largest holder of Edgewise Therapeutics. The company owns 6.37M of the company's shares outstanding (worth $116.11M).